The ECCO and the ESGAR have developed new comprehensive and user-friendly guidelines for IBD. The key areas are initial diagnosis and monitoring of therapy, complications, endoscopic and clinical scoring, and general principles as well as technical aspects of IBD.
Upper gastrointestinal endoscopy is (still) recommended for Crohn’s disease (CD) patients with upper gastrointestinal symptoms, but it is no longer recommended for asymptomatic, newly diagnosed patients. They should undergo small bowel assessment, with the preferred method depending on local availability and expertise. Capsule endoscopy has good sensitivity for early mucosal inflammation, but can only detect mucosal changes. Magnetic resonance imaging (MRI) and intestinal ultrasound (IUS) can describe the transmural inflammation and detect complications such as fistulas. MRI can also detect deep ulcerations, and thickened small bowel walls. IUS can be performed by the treating gastroenterologis...
Please login to read the full text of the article.
If you have no account yet, please register now.
« Letter from The Editor Next Article
Comparative effectiveness of vedolizumab and ustekinumab in CD »